Literature DB >> 16740526

Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1.

G Altarescu1, B Brooks, Y Kaplan, T Eldar-Geva, E J Margalioth, E Levy-Lahad, P Renbaum.   

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder caused by mutations in the neurofibromin gene. Approximately, 50% of cases are caused by de-novo mutations. Even when the NF1 mutation is known, accuracy of PGD is highly enhanced by simultaneous analysis of linked markers. In a childless couple referred to PGD, the male carried a de-novo mutation, precluding the possibility of typing relatives to establish the mutation-associated haplotype. We developed a single-sperm haplotype analysis strategy to establish the haplotype linked to the NF1 mutation.
METHODS: Spermatozoa from freshly ejaculated semen were used as a substrate for multiplex PCR on single sperm.
RESULTS: In addition to the NF1 mutation, six informative polymorphic markers flanking the NF1 gene (D17S1294, D17S1849, D17S841, D17S975, NF1TG2 and NF1AC5) were linked to individual alleles in single sperm from the affected male.
CONCLUSIONS: Single-sperm analysis established the haplotypes of both mutant and wild-type NF1 alleles and enabled the implementation of a PGD protocol using polymorphic marker analysis. This method is generally applicable to PGD for any disease in which the haplotype of paternal mutations cannot be determined by typing relatives.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740526     DOI: 10.1093/humrep/del064

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Familial haplotyping and embryo analysis for Preimplantation genetic diagnosis (PGD) using DNA microarrays: a proof of principle study.

Authors:  G Altarescu; D A Zeevi; S Zeligson; S Perlberg; T Eldar-Geva; E J Margalioth; E Levy-Lahad; P Renbaum
Journal:  J Assist Reprod Genet       Date:  2013-07-06       Impact factor: 3.412

2.  Evaluation of PCR-based preimplantation genetic diagnosis applied to monogenic diseases: a collaborative ESHRE PGD consortium study.

Authors:  Jos Dreesen; Aspasia Destouni; Georgia Kourlaba; Birte Degn; Wulf Christensen Mette; Filipa Carvalho; Celine Moutou; Sioban Sengupta; Seema Dhanjal; Pamela Renwick; Steven Davies; Emmanouel Kanavakis; Gary Harton; Joanne Traeger-Synodinos
Journal:  Eur J Hum Genet       Date:  2013-12-04       Impact factor: 4.246

3.  Single-sperm analysis for recurrence risk assessment of spinal muscular atrophy.

Authors:  Philippe Burlet; Nadine Gigarel; Maryse Magen; Séverine Drunat; Alexandra Benachi; Laetitia Hesters; Arnold Munnich; Jean-Paul Bonnefont; Julie Steffann
Journal:  Eur J Hum Genet       Date:  2009-11-11       Impact factor: 4.246

4.  Improving preimplantation genetic diagnosis (PGD) reliability by selection of sperm donor with the most informative haplotype.

Authors:  Mira Malcov; Veronica Gold; Sagit Peleg; Tsvia Frumkin; Foad Azem; Ami Amit; Dalit Ben-Yosef; Yuval Yaron; Adi Reches; Shimi Barda; Sandra E Kleiman; Leah Yogev; Ron Hauser
Journal:  Reprod Biol Endocrinol       Date:  2017-04-26       Impact factor: 5.211

5.  De Novo Paternal FBN1 Mutation Detected in Embryos Before Implantation.

Authors:  Shuling Wang; Ziru Niu; Hui Wang; Minyue Ma; Wei Zhang; Shu Fang Wang; Jun Wang; Hong Yan; Yifan Liu; Na Duan; Xiandong Zhang; Yuanqing Yao
Journal:  Med Sci Monit       Date:  2017-06-26

6.  Using affected embryos to establish linkage phase in preimplantation genetic testing for thalassemia.

Authors:  Zhanhui Ou; Yu Deng; Yunhao Liang; Zhiheng Chen; Ling Sun
Journal:  Reprod Biol Endocrinol       Date:  2022-04-30       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.